The ongoing supply issues surrounding pancreatic enzyme replacement therapy have progressed. These intermittent supply issues mean some people are running out of PERT, or experiencing difficulties or delays in accessing PERT. Therefore, there is a need for clinical and symptom management advice that is different to normal clinical practice.
